StockDriftsStockDriftsTop 2 Athyrium Capital Management, Lp Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| BIOR | Biora Therapeutics Inc. | 63.12% | 10.93M | $5.5M | +0.00%(+0) | — | 2024-09-30 | |
| PBYI | PUMA BIOTECHNOLOGY INC | 36.88% | 1.26M | $3.2M | +0.00%(+0) | — | 2024-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Athyrium Capital Management, Lp reports $8.69M in US-listed equity holdings across 2 positions in its most recent 13F filing. Its largest disclosed positions are BIOR (63.1%) and PBYI (36.9%). Figures reflect the Q3 2024 filing.
Sign up free to track Athyrium Capital Management, Lp, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Athyrium Capital Management, Lp’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1728001). View Athyrium Capital Management, Lp’s 13F filings on SEC